BUONO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 228
EU - Europa 117
AS - Asia 64
AF - Africa 7
Totale 416
Nazione #
US - Stati Uniti d'America 223
IT - Italia 57
SG - Singapore 39
CN - Cina 19
NL - Olanda 17
DE - Germania 16
CI - Costa d'Avorio 6
IE - Irlanda 6
CA - Canada 5
FR - Francia 5
GB - Regno Unito 4
IN - India 4
DK - Danimarca 2
FI - Finlandia 2
VN - Vietnam 2
BE - Belgio 1
ES - Italia 1
GR - Grecia 1
LT - Lituania 1
MC - Monaco 1
NG - Nigeria 1
RO - Romania 1
RU - Federazione Russa 1
SE - Svezia 1
Totale 416
Città #
Chandler 45
Singapore 34
Ashburn 21
Santa Clara 17
Amsterdam 16
Millbury 13
Seattle 8
Casoria 6
Milan 5
Princeton 5
Beijing 4
Des Moines 4
Munich 4
Pune 4
Lawrence 3
Nanjing 3
Ottawa 3
Boston 2
Dearborn 2
Dong Ket 2
Fairfield 2
Jiaxing 2
London 2
Naples 2
Pomigliano d'Arco 2
Redwood City 2
Teano 2
Tianjin 2
Toronto 2
Wilmington 2
Athens 1
Augusta 1
Boardman 1
Brussels 1
Casalnuovo 1
Caserta 1
Changsha 1
Changteh 1
Dallas 1
Dongyang 1
Falkenstein 1
Hebei 1
Lagos 1
Lappeenranta 1
Los Angeles 1
Monaco 1
Montemesola 1
Napoli 1
Nuremberg 1
Palagonia 1
Rome 1
San Jose 1
Shenyang 1
Turin 1
Vetralla 1
Washington 1
Wuhan 1
Totale 248
Nome #
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 65
The Impact of Translational Research in Breast Cancer Care: Can We Improve the Therapeutic Scenario? 55
Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study 48
Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women 44
Combined effect of obesity and diabetes on early breast cancer outcome: A prospective observational study 40
Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series 37
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study 37
PI3K/mTOR Inhibitors in the Treatment of Luminal Breast Cancer. Why, When and to Whom? 35
Prevalence of Sarcopenia in Women with Breast Cancer 30
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time? 24
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study 22
Totale 437
Categoria #
all - tutte 2.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.337


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 2 2 0 1 5 0
2020/202140 1 0 3 0 10 2 10 3 6 0 2 3
2021/202265 0 0 1 0 1 3 0 3 7 5 23 22
2022/2023103 8 10 3 3 18 12 2 8 16 18 5 0
2023/202481 1 14 6 4 2 18 0 17 1 1 11 6
2024/202576 16 2 4 12 18 23 1 0 0 0 0 0
Totale 437